Data Warehouses Ascend to the Cloud

whitePaper | January 27, 2020

AWS maintains a standards-based risk management program to ensure that the HIPAA-eligible services specifically support the administrative, technical, and physical safeguards required under HIPAA. Using these services to store, process, and transmit PHI allows our customers and AWS to address the HIPAA requirements applicable to the AWS utility-based operating model.

whitePaper | December 22, 2022

We live in a digital world in which data analytics and artificial intelligence significantly impact our daily lives. They influence what we wear, what we eat, where we travel, and how we spend our free time. In medicine the impact of data has much more drastic effects, as access to high-quality medical data is a matter of life or death for patients every day. In this particular area, the desire to save human life by discovering modern methods of therapy and diagnostics often contradicts another fundamental right of the patient - the right to privacy and the right to dispose of one’s data.

whitePaper | June 10, 2022

The past few years have witnessed exponential growth in data volumes, forms and sources of data. To handle this ever increasing complexity and dimensionality, an Intelligent Framework for knowledge discovery is required. This framework should also support text analysis, visualization, intelligent search, man-machine interface, data management, geo-spatial, temporal data processing including statistics processing. A holistic approach based on Artificial Intelligence and Advanced Analytics provides such a framework. It brings forth a breakthrough natural language-based cognitive technology, which provides instant access to powerful predictive and visual analytic tools for businesses in general and market research in particular.

whitePaper | September 12, 2022

This whitepaper examines clinical trial data contribution policies and the data protection methodologies applied to protect patient privacy. Information published by 29 biopharma sponsors was collected across three data-sharing platforms, collated by sponsor size. Results showed that large sponsor contribution policies can provide helpful benchmarks for medium and smaller sponsors.

whitePaper | June 24, 2022

The reactive approach to discovering, analyzing, and correcting data quality issues in business applications has been marginally effective throughout the era of data consolidation for analytics (data warehousing, etc.) and the subsequent onset of “big data.”

whitePaper | May 15, 2023

Genomics is the study of the complete set of DNA in a person or other organism. DNA underpins a large proportion of an individual's health and disease status, therefore a genomic medicine approach is increasingly being applied in clinical settings. Genomic medicine is where the study of clinical outcomes (measurable changes in health and well-being) is combined with genomics so researchers can better understand how a person’s genome contributes to disease. Increasingly, advances in our understanding of the genome are contributing to improvements in disease diagnosis, drug discovery and targeted therapeutics.